NEW YORK, Oct. 11, 2023 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of Humanigen, Inc. Humanigen, Inc.'s securities were suspended on July 26, 2023, and have not
NEW YORK, Oct. 11, 2023 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of Humanigen, Inc. Humanigen,...
Gainers Gaucho Group Holdings, Inc. (NASDAQ: VINO) jumped 95.2% to $3.7280. Gaucho Group is planning to list two of its retail properties in Argentina, in San Rafael and Cordoba, for sale, priced at $2 million and $0.7 million respectively.
U.S. stocks traded lower toward the end of trading, with the Dow Jones falling more than 150 points on Tuesday. The Dow traded down 0.48% to 34,457.36 while the NASDAQ fell 0.28% to 13,672.29. The S&P 500 also fell, dropping, 0.34% to 4,438.52.
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data....
Looking For Penny Stocks to Watch? Check Out These 4
While February has not been the best month for blue-chip stocks, many penny stocks have climbed in the pas...
List Of Penny Stocks To Watch If Biotech Is Your Focus In Q1
When it comes to penny stocks, traders look for volatile sectors & industries. One of the more vol...
Today's Daily Dose brings you news about another Alzheimer's disease drug failure, encouraging data of Aclaris' rheumatoid arthritis trial; Royalty Pharma/Minerva deal; Gritstone joining the COVID-19 vaccine race; and FDA imposing a clinical hold on Histogen's planned trial of HST-003 for knee cartilage regeneration.